Abstract
Numerous technologic advances have been and continue to be developed in the areas of insulin delivery and glucose sensing. These advances have evolved to allow individuals with diabetes to obtain the best glucose control possible while minimizing the risk of hypoglycemia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
JDRF CGM Study Group: JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther 2008, 10:310–321.
The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; Tamborlane WV, Beck RW, Bode BW, et al.: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008, 359:1464–1476.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009, 32:1378–1383.
The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; Beck RW, Buckingham B, Miller K, et al.: Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009, 32:1947–1953.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; Bode B, Beck RW, Xing D, et al.: Sustained benefit of continuous glucose monitoring on HbA1c, glucose profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care 2009, 32:2047–2049.
Bode BW, Gross TM, Thornton KR, et al.: Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999, 46:183–190.
Davidson P, Hebblewhite H, Steed RD, Bode BW: Analysis: the suboptimal roadmap to the intensive therapy target. Diabetes Technol Ther 2004, 6:17–19.
Davidson P, Hebblewhite H, Steed RD, Bode BW: Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract 2008, 14:1095–1101.
Weinzimer SA, Steil GM, Swan KL, et al.: Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using the artificial pancreas. Diabetes Care 2008, 31:934–939.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Bode, B.W. (2012). Technology and Diabetes: Insulin Delivery Systems and Glucose Sensing. In: Skyler, J. (eds) Atlas of Diabetes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-1028-7_17
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1028-7_17
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-1027-0
Online ISBN: 978-1-4614-1028-7
eBook Packages: MedicineMedicine (R0)